Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peppa, M.
Right arrow Articles by Vlassara, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peppa, M.
Right arrow Articles by Vlassara, H.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:1441-1448, 2003
© 2003 by the American Diabetes Association, Inc.

Fetal or Neonatal Low-Glycotoxin Environment Prevents Autoimmune Diabetes in NOD Mice

Melpomeni Peppa1, Cijiang He1, Masakazu Hattori2, Robert McEvoy1, Feng Zheng1, and Helen Vlassara1

1 Division of Experimental Diabetes and Aging, Department of Geriatrics, Mount Sinai School of Medicine, New York, New York
2 Joslin Diabetes Center, Boston, Massachusetts

Advanced glycation end products (AGEs) are implicated in ß-cell oxidant stress. Diet-derived AGE (dAGE) are shown to contribute to end-organ toxicity attributed to diabetes. To assess the role of dAGE on type 1 diabetes, NOD mice were exposed to a high-AGE diet (H-AGE) and to a nutritionally similar diet with approximate fivefold-lower levels of N{epsilon}-carboxymethyllysine (CML) and methylglyoxal-derivatives (MG) (L-AGE). Suppression of serum CML and MG in L-AGE-fed mice was marked by suppression of diabetes (H-AGE mice >94% vs. L-AGE mice 33% in founder [F]0, 14% in F1, and 13% in F2 offspring, P < 0.006) and by a delay in disease onset (4-month lag). Survival for L-AGE mice was 76 vs. 0% after 44 weeks of H-AGE mice. Reduced insulitis in L-AGE versus H-AGE mice (P < 0.01) was marked by GAD- and insulin-unresponsive pancreatic interleukin (IL)-4-positive CD4+ cells compared with the GAD- and insulin-responsive interferon (IFN)-{gamma}-positive T-cells from H-AGE mice (P < 0.005). Splenocytes from L-AGE mice consisted of GAD- and insulin-responsive IL-10-positive CD4+ cells compared with the IFN-{gamma}-positive T-cells from H-AGE mice (P < 0.005). Therefore, high AGE intake may provide excess antigenic stimulus for T-cell-mediated diabetes or direct ß-cell injury in NOD mice; both processes are ameliorated by maternal or neonatal exposure to L-AGE nutrition.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. Uribarri, W. Cai, M. Peppa, S. Goodman, L. Ferrucci, G. Striker, and H. Vlassara
Circulating Glycotoxins and Dietary Advanced Glycation Endproducts: Two Links to Inflammatory Response, Oxidative Stress, and Aging
J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2007; 62(4): 427 - 433.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. G. Huebschmann, J. G. Regensteiner, H. Vlassara, and J. E.B. Reusch
Diabetes and Advanced Glycoxidation End Products.
Diabetes Care, June 1, 2006; 29(6): 1420 - 1432.
[Full Text] [PDF]


Home page
DiabetesHome page
O. Sandu, K. Song, W. Cai, F. Zheng, J. Uribarri, and H. Vlassara
Insulin Resistance and Type 2 Diabetes in High-Fat-Fed Mice Are Linked to High Glycotoxin Intake
Diabetes, August 1, 2005; 54(8): 2314 - 2319.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
H. VLASSARA
Advanced Glycation in Health and Disease: Role of the Modern Environment
Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 452 - 460.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
J. URIBARRI, W. CAI, O. SANDU, M. PEPPA, T. GOLDBERG, and H. VLASSARA
Diet-Derived Advanced Glycation End Products Are Major Contributors to the Body's AGE Pool and Induce Inflammation in Healthy Subjects
Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
K. SEBEKOVA, T. HOFMANN, P. BOOR, K. SEBEKOVA JR., O. ULICNA, H. F. ERBERSDOBLER, J. W. BAYNES, S. R. THORPE, A. HEIDLAND, and V. SOMOZA
Renal Effects of Oral Maillard Reaction Product Load in the Form of Bread Crusts in Healthy and Subtotally Nephrectomized Rats
Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 482 - 491.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Chen, S. S. Yan, J. Colgan, H.-P. Zhang, J. Luban, A. M. Schmidt, D. Stern, and K. C. Herold
Blockade of Late Stages of Autoimmune Diabetes by Inhibition of the Receptor for Advanced Glycation End Products
J. Immunol., July 15, 2004; 173(2): 1399 - 1405.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Peppa, H. Brem, P. Ehrlich, J.-G. Zhang, W. Cai, Z. Li, A. Croitoru, S. Thung, and H. Vlassara
Adverse Effects of Dietary Glycotoxins on Wound Healing in Genetically Diabetic Mice
Diabetes, November 1, 2003; 52(11): 2805 - 2813.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.